1st Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

Firm
Client
Income
—
Expenses
$192,731
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Biodefense Advanced Research and Development Authority (BARDA-HHS) funding in Supplemental and FY-2010 Budget. Vaccines and Therapeutics for CBRN threats. Education of Congressional Members and Staff on biological-chemical terrorist threat to the U.S. FY-2010 Defense Appropriations requests for Chemical Nerve Agent Antidote and Anthrax Therapeutic Monoclonal Antibody

LobbyistCovered position, as disclosed
MARK EDWARD COOKE —

Contacted: Natl Institutes of Health (NIH); Defense, Dept of (DOD); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.